title: Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.
authors.affiliation: Service de Maladies Infectieuses, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France. gilles.raguin@medecinsdumonde.net
authors.forename: Gilles
authors.initials: G
authors.lastname: Raguin
authors.forename: Geneviève
authors.initials: G
authors.lastname: Chêne
authors.forename: Laurence
authors.initials: L
authors.lastname: Morand-Joubert
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Taburet
authors.forename: Cécile
authors.initials: C
authors.lastname: Droz
authors.forename: Clotilde
authors.initials: C
authors.lastname: Le Tiec
authors.forename: François
authors.initials: F
authors.lastname: Clavel
authors.forename: Pierre-Marie
authors.initials: PM
authors.lastname: Girard
mesh_terms: D000328:Adult; D000368:Aged; D002219:Carbamates; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D005663:Furans; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use*; D016879:Salvage Therapy; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D012367:RNA, Viral; D013449:Sulfonamides; D061466:Lopinavir; C095108:amprenavir; D019438:Ritonavir